Received Apr 24, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 2 | 947984 | IM / LA |
Patient received first dose on 4/10/2026 and second dose on 4/24/26. Patient did not have any symptoms
none
none
famotidine
none
none